Skip to main content
William A. Fischer II, MD - Division of Pulmonary Diseases and Critical Care Medicine

William A. Fischer II, MD

Associate Professor of Medicine

Director of Emerging Pathogens Institute for Global Health and Infectious Diseases

william-fischer-experimental-pill-treat-COVID

Contact Information

Resources

William A. Fischer II, MD

Associate Professor of Medicine

Director of Emerging Pathogens Institute for Global Health and Infectious Diseases

Areas of Interest

Severe Viral Infections and Emerging Infectious Diseases

About

Severe acute viral infections are one of the world’s most common causes of hospitalization and mortality with worse outcomes disproportionately affecting resource constrained countries. In the past 15 years we have witnessed the emergence or re-emergence of several viral pathogens that threaten global public health including SARS, pandemic H1N1 Influenza, MERS-CoV, and most recently Ebola. The focus of our group is to better understand host factors that underly susceptibility to severe viral infections, evaluate novel therapeutic interventions to improve mortality from severe viral infections, and to operationalize these interventions in resource constrained settings.

 

  • BS

    Bates College

  • MD

    The University of North Carolina School of Medicine

  • Residency

    The Johns Hopkins Hospital

  • Fellowship

    The Johns Hopkins Hospital